Metagenomi, Inc. Common Stock
MGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $135,081 | $386,340 | $386,340 | $61,135 |
| - Cash | $27,386 | $140,603 | $184,441 | $39,296 |
| + Debt | $45,778 | $48,229 | $18,571 | $48,928 |
| Enterprise Value | $153,473 | $293,966 | $220,470 | $70,767 |
| Revenue | $52,295 | $44,756 | $17,200 | $243 |
| % Growth | 16.8% | 160.2% | 6,978.2% | – |
| Gross Profit | $52,295 | -$49,647 | $15,467 | -$144 |
| % Margin | 100% | -110.9% | 89.9% | -59.3% |
| EBITDA | -$83,494 | -$74,285 | -$39,193 | -$20,753 |
| % Margin | -159.7% | -166% | -227.9% | -8,540.3% |
| Net Income | -$78,058 | -$68,255 | -$43,593 | -$21,442 |
| % Margin | -149.3% | -152.5% | -253.4% | -8,823.9% |
| EPS Diluted | -2.09 | -1.82 | -1.16 | -3.62 |
| % Growth | -14.8% | -56.9% | 68% | – |
| Operating Cash Flow | -$109,073 | -$91,409 | $29,724 | $24,257 |
| Capital Expenditures | -$3,114 | -$9,814 | -$13,977 | -$2,903 |
| Free Cash Flow | -$112,187 | -$101,223 | $15,747 | $21,354 |